Log in to save to my catalogue

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutami...

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutami...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84a852fcb0624999ab330bdca23f4d3f

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The androgen receptor (AR) signaling inhibitor enzalutamide (enza) is one of the principal treatments for metastatic castration-resistant prostate cancer (CRPC). Several emergent enza clinical resistance mechanisms have been described, including lineage plasticity in which the tumors manifest reduced dependency on the AR. To improve our understandi...

Alternative Titles

Full title

Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_84a852fcb0624999ab330bdca23f4d3f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84a852fcb0624999ab330bdca23f4d3f

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-32701-6

How to access this item